WuXi AppTec acquires ResearchPoint Global

WuXi AppTec, a global pharmaceutical, biotechnology and medical device open-access capability and technology platform, has acquired ResearchPoint Global (RPG), a U.S.-based CRO with expertise spanning across all major therapeutic areas. Upon the closing of this acquisition, RPG will become a wholly-owned subsidiary of WuXi, and will continue to focus on growing its core competences and providing better clinical development services. The acquisition underscores a strategic step forward to expand WuXi’s clinical research capabilities in the U.S. and around the world, further strengthening WuXi’s integrated R&D capability platform.

[Read More]

The Pulse

The Pulse on Global Trials by Matthew Howes

In recent years, a global talent shortage has hampered strategic growth for many organizations. According to the ManPower Group, 36% of employers globally report talent shortages, the highest in seven years.

[Read More]

Clinical Intelligence

Awards & Advancement


Nasdaq GlobeNewswire